{"filing":{"accession_number":"0000950157-26-000700","cik":"0000875045","ticker":"BIIB","company_name":"BIOGEN INC.","form":"8-K","filing_date":"2026-06-10","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/875045/000095015726000700/form8-k.htm"},"events":[{"id":5578,"run_id":4894,"accession_number":"0000950157-26-000700","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the final voting results from Biogen's June 9, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for three matters: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. These are routine but material shareholder governance matters that affect investor understanding of board composition and corporate oversight.","company_name":"BIOGEN INC.","ticker":"BIIB","filing_date":"2026-06-10","form":"8-K","submitted_at":null,"items":[{"id":5943,"accession_number":"0000950157-26-000700","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final voting results from Biogen's June 9, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for three matters: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. These are routine but material shareholder governance matters that affect investor understanding of board composition and corporate oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:55:06.050403+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5943,"accession_number":"0000950157-26-000700","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final voting results from Biogen's June 9, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for three matters: election of ten directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. These are routine but material shareholder governance matters that affect investor understanding of board composition and corporate oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-10T20:55:06.050403+00:00","company_name":"BIOGEN INC.","ticker":"BIIB","filing_date":"2026-06-10"}]}